Subfoveal choroidal neovascularisation (CNV)
Treatment Phase: Initial treatment
Treatment criteria:
-
Must be treated by an ophthalmologist or by an accredited ophthalmology registrar in consultation with an ophthalmologist.
Clinical criteria:
-
The condition must be due to age-related macular degeneration (AMD),
AND
-
The condition must be diagnosed by optical coherence tomography; OR
-
The condition must be diagnosed by fluorescein angiography,
AND
-
The treatment must be the sole PBS-subsidised therapy for this condition.
Authority approval for initial treatment of each eye must be sought.
The first authority application for each eye must be made via the Online PBS Authorities System (real time assessment) or in writing via HPOS form upload or mail and must include:
(1) Details (date, unique identifying number/code or provider number) of the optical coherence tomography or fluorescein angiogram report.
If the application is submitted through HPOS form upload or mail, it must include:
(a) details of the proposed prescription; and
(b) a completed authority application form relevant to the indication and treatment phase (the latest version is located on the website specified in the Administrative Advice).
All reports must be documented in the patient's medical records.